Roswell Park Comprehensive Cancer Center

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Redirect Template:Promotional Template:Use American English Template:Use mdy dates Template:Infobox hospital Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research.<ref>Template:Cite journal</ref><ref name=":2">Template:Cite news</ref><ref name=":0">Template:Cite news</ref> The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is Template:As of, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

The Roswell Park campus, spread out in 15 separate buildings of approximately two million square feet, occupies Template:Convert on the Template:Convert Buffalo Niagara Medical Campus (BNMC) in downtown Buffalo, and includes Template:Convert of space equally distributed between clinical programs and research/education functions. A separate hospital building, completed in 1998, houses a diagnostic and treatment center. The campus also includes a medical research complex as well as research and education focused spaces.

Template:TOC limit

History

In 1898, the program that would later become the cancer center was established by Roswell Park, who was a professor of surgery at the University of Buffalo School of Medicine.<ref name=":1">Template:Cite book</ref> Park said that "Only through a deliberate well-planned, combined attack from various directions by means fitted for such work could real advances be made and further the relationship of laboratory work, clinical study and education must be closely associated."<ref name=":1" />

Research started in three rooms in the University of Buffalo School of Medicine but not long thereafter, it outgrew the rooms. Seeing the importance of dedicated cancer research, select Buffalo citizens donated funds to purchase land and construct a new building. The largest contributor was Mrs. William Gratwick (wife of William H. Gratwick, the founder of Gratwick, Smith & Fryer Lumber Co.), who donated $25,000. The Gratwick Research Laboratory of the University of Buffalo was constructed in 1901 and was located at High and Elm streets.<ref>Template:Cite book</ref>

Park wrote books, gave lectures, and was the administrator at the cancer research center. In 1904, Park stepped down and Harvey R. Gaylord took over as the center's second director. Park remained as the chairman of the board of trustees.<ref>Template:Cite book</ref>

In coming decades the center was renamed the Roswell Park Cancer Institute, a name it retained for decades until 2018, when its current name was implemented. The Roswell Park Cancer Institute was usually called Roswell Park or RPCI for short.

Notable facts

  • Founded in 1898 as the world's first institute devoted exclusively to cancer research<ref>Template:Cite news</ref> 1884 – On May 31, Memorial Sloan Kettering Cancer Center is founded as New York Cancer Hospital at 106th Street and Central Park West in Manhattan. New York Cancer Hospital is the first institution in the United States devoted exclusively to the treatment and research of cancer.
  • Gerty Cori was the first woman to receive the Nobel Prize in Physiology or Medicine.<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>

  • The center's first female leader, Candace S. Johnson was named President & CEO in February 2015.<ref>Template:Cite news</ref>
  • Leads New York State in the number of robotic cystectomies performed<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>

  • Established one of the nation's first long-term survivors clinics for childhood cancer patients<ref>Template:Cite news</ref>

Discoveries and advancements in cancer care

Discovery of how the human body converts glucose to glycogen

File:Gerty Theresa Radnitz Cori (1896-1957) and Carl Ferdinand Cori - restoration1.jpg
Gerty Cori and Carl Cori jointly won the 1947 Nobel Prize in Physiology or Medicine for their discovery of the way in which the body converts glucose to glycogen.

Drs. Gerty and Carl Cori jointly won the 1947 Nobel Prize in Physiology or Medicine, "for their discovery of the course of the catalytic conversion of glycogen."<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> Their research leading to the discovery began during their tenure at Roswell Park (then called the New York State Institute for the Study of Malignant Diseases), from 1922 to 1931.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Alternative breast cancer treatments

Thomas Dao (1921–2009), served as director of the breast surgery department from 1957 to 1988, where he developed breast cancer treatment alternatives.<ref>Template:Cite news</ref>

Development of photodynamic therapy

In 1975, Thomas Dougherty successfully treated preclinical models of cancer using photodynamic therapy (PDT) techniques for the first time.<ref>Template:Cite journal</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> In 1978, he conducted the first PDT clinical trial.<ref>Template:Cite journal</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> Today, PDT is an FDA-approved method for treating specific kinds of cancer, and is used around the world.

Discovery of PSA

Research resulting in the discovery of the prostate-specific antigen (PSA) was led by T. Ming Chu in the 1970s.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> His team subsequently developed a way to detect the PSA protein in blood as a simple diagnostic test.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> Since its FDA approvals in 1986 and 1994, an estimated one billion PSA tests have been given.

Research on 5-fluorouracil + leucovorin

Biochemist Marie Hakala, PhD<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> first observed that 5-fluorouracil becomes more effective in treating cancer cells when calcium leucovorin is added.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> This discovery paved the way for the development of 5-FU + leucovorin therapy, which was for many years the gold standard of chemotherapy for colorectal cancer.

Research on SurVaxM

SurVaxM, a cancer immunotherapy vaccine, was awarded orphan drug status by the United States Food and Drug Administration in 2017. A phase II clinical trial of SurVaxM has shown that the vaccine, when combined with standard therapy, is more effective than standard therapies alone.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Organization

Education

Roswell Park offers both Master's and PhD programs in Cancer Sciences.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> These programs are offered in collaboration with the University at Buffalo Jacobs School of Medicine.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Reputation

Roswell Park Comprehensive Cancer Center has received numerous accolades for the quality of healthcare provided.

  • In 2020, Roswell Park ranked #14 on U.S. News & World Report's list of the best cancer hospitals in the country,<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> and was ranked High Performing in the areas of colon cancer surgery<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> and lung cancer surgery.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

  • Roswell Park has received recognition from Blue Cross Blue Shield as a Blue Distinction Center for Cancer Care,<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref> Blood and Marrow Transplants,<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> and Cellular Immunotherapy.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

|CitationClass=web }}</ref>

|CitationClass=web }}</ref>

  • Roswell Park is recognized as an Optum Cancer Center of Excellence.<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>

  • The Lung Cancer Alliance has recognized Roswell Park as a Screening Center of Excellence.<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>

|CitationClass=web }}</ref>

Accreditation

Template:Div col

|CitationClass=web }}</ref>

  • Society of Surgical Oncology - Surgical Oncology Training Program
  • National Accreditation Program for Breast CancersTemplate:Div col end

Patient care

File:Scott Bieler Clinical Sciences Center, Buffalo, New York - 20200507.jpg
Scott Bieler Clinical Sciences Center

Roswell Park provides comprehensive care for a wide range of cancers.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Template:Div col

Specialized treatments

Roswell Park offers specialized treatments, services and therapies to treat cancer, as well as services to support patients undergoing cancer treatment.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> Template:Div col

Collaborations

CIMAvax

Roswell Park was the first American institution to receive FDA permission to conduct clinical trials of CIMAvax, a Cuban medical therapy developed by Centro de Immunologica Molecular, La Habana, Cuba.<ref>Template:Cite news</ref><ref>Template:Cite news</ref>

Ovarian Cancer SPORE

The Ovarian Cancer SPORE is a collaboration between Roswell Park and University of Pittsburgh Cancer Institute (UPCI). The SPORE project includes multiple research projects, core supportive structures, and career development programs.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Cancer Registries

Stacey Scott Lung Cancer Registry

Together with the British Columbia Cancer Agency, Vancouver, Canada and Vrije Universiteit, Amsterdam, the Netherlands, Roswell Park manages the Stacey Scott Lung Cancer Registry.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Familial Ovarian Cancer Registry

Founded in 1990 by Steven Piver, the Familial Ovarian Cancer Registry houses information relating to family history and lifestyle of patients and families with histories of ovarian cancer.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Research and training collaborations

Roswell Park collaborates with institutions around the world to strengthen cancer training and research programs.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

See also

Template:Portal

References

Template:Reflist

Template:New York state public-benefit corporations

Template:Authority control

Retrieved from "https://wiki.sarg.dev/index.php?title=Roswell_Park_Comprehensive_Cancer_Center&oldid=745289"